卡培他滨联合顺铂用于局部晚期鼻咽癌患者的新辅助化疗：病例系列研究
Neoadjuvant Chemotherapy With Capecitabine Plus Cisplatin in Patients With Locally Advanced Nasopharyngeal Cancer: Case Series Study.
作者信息
Dada Reyad, El Sayed Mohamed, Zekri Jamal
机构信息
, , and , King Faisal Specialist Hospital and Research Center, Jeddah; and , Al-Faisal University, Riyadh, Kingdom of Saudi Arabia; and , Cairo University, Cairo, Egypt.
出版信息
J Glob Oncol. 2016 Nov 16;3(5):455-458. doi: 10.1200/JGO.2016.006924. eCollection 2017 Oct.
Abstract
PURPOSE
Capecitabine, an oral fluorouracil (5-FU) derivative, has replaced 5-FU in many chemotherapy regimens used in various GI tract cancers. The experience with capecitabine in nasopharyngeal carcinoma (NPC) is limited.
PATIENTS AND METHODS
We report on eight patients with locally advanced NPC treated with neoadjuvant chemotherapy with capecitabine and cisplatin.
RESULTS
All eight patients responded well to the chemotherapy combination and achieved complete remission after definitive chemoradiotherapy. No grade 3/4 toxicities were observed. Five patients experienced a relapse after 6, 8, 9, 12, and 17 months.
CONCLUSION
In the patients studied, capecitabine (in combination with cisplatin) was a safe and effective substitution for 5-FU for the neoadjuvant treatment of locally advanced NPC. Larger prospective clinical studies are required to confirm these results.
摘要
目的
卡培他滨是一种口服氟尿嘧啶（5-FU）衍生物，在多种胃肠道癌症的化疗方案中已取代5-FU。卡培他滨在鼻咽癌（NPC）中的应用经验有限。
患者与方法
我们报告了8例局部晚期鼻咽癌患者，接受了卡培他滨和顺铂的新辅助化疗。
结果
所有8例患者对化疗联合方案反应良好，在确定性放化疗后实现完全缓解。未观察到3/4级毒性反应。5例患者在6、8、9、12和17个月后复发。
结论
在所研究的患者中，卡培他滨（联合顺铂）是5-FU用于局部晚期鼻咽癌新辅助治疗的安全有效替代药物。需要更大规模的前瞻性临床研究来证实这些结果。
相似文献
1
Neoadjuvant Chemotherapy With Capecitabine Plus Cisplatin in Patients With Locally Advanced Nasopharyngeal Cancer: Case Series Study.卡培他滨联合顺铂用于局部晚期鼻咽癌患者的新辅助化疗：病例系列研究
J Glob Oncol. 2016 Nov 16;3(5):455-458. doi: 10.1200/JGO.2016.006924. eCollection 2017 Oct.
2
Neoadjuvant chemotherapy followed by concurrent chemoradiation for locally advanced nasopharyngeal carcinoma.新辅助化疗后序贯同步放化疗治疗局部晚期鼻咽癌。
Chin J Cancer. 2010 May;29(5):551-5. doi: 10.5732/cjc.009.10518.
3
Neoadjuvant chemotherapy followed by concurrent chemoradiation for locoregionally advanced nasopharyngeal carcinoma: interim results from 2 prospective phase 2 clinical trials.新辅助化疗后同期放化疗治疗局部晚期鼻咽癌：2 项前瞻性 2 期临床试验的中期结果。
Cancer. 2013 Dec 1;119(23):4111-8. doi: 10.1002/cncr.28324. Epub 2013 Aug 27.
4
Preliminary results of trial NPC-0501 evaluating the therapeutic gain by changing from concurrent-adjuvant to induction-concurrent chemoradiotherapy, changing from fluorouracil to capecitabine, and changing from conventional to accelerated radiotherapy fractionation in patients with locoregionally advanced nasopharyngeal carcinoma.NPC-0501试验的初步结果，该试验评估了局部晚期鼻咽癌患者从同步辅助放化疗改为诱导-同步放化疗、从氟尿嘧啶改为卡培他滨以及从常规放疗分割改为加速放疗分割后的治疗获益情况。
Cancer. 2015 Apr 15;121(8):1328-38. doi: 10.1002/cncr.29208. Epub 2014 Dec 19.
5
Phase II study of capecitabine and cisplatin combination as first-line chemotherapy in Chinese patients with metastatic nasopharyngeal carcinoma.卡培他滨和顺铂联合作为中国转移性鼻咽癌患者一线化疗的II期研究。
Cancer Chemother Pharmacol. 2008 Aug;62(3):539-44. doi: 10.1007/s00280-007-0641-2. Epub 2008 Jan 3.
6
Neoadjuvant Chemotherapy with Fluorouracil plus Nedaplatin or Cisplatin for Locally Advanced Nasopharyngeal Carcinoma: a Retrospective Study.氟尿嘧啶联合奈达铂或顺铂新辅助化疗治疗局部晚期鼻咽癌的回顾性研究
J Cancer. 2018 Sep 8;9(20):3676-3682. doi: 10.7150/jca.27198. eCollection 2018.
7
Neoadjuvant chemotherapy plus intensity-modulated radiotherapy versus concurrent chemoradiotherapy plus adjuvant chemotherapy for the treatment of locoregionally advanced nasopharyngeal carcinoma: a retrospective controlled study.新辅助化疗联合调强放疗与同步放化疗联合辅助化疗治疗局部晚期鼻咽癌的回顾性对照研究
Chin J Cancer. 2016 Jan 6;35:2. doi: 10.1186/s40880-015-0076-9.
8
Experience with combination of docetaxel, cisplatin plus 5-fluorouracil chemotherapy, and intensity-modulated radiotherapy for locoregionally advanced nasopharyngeal carcinoma.局部晚期鼻咽癌多西他赛、顺铂加 5-氟尿嘧啶化疗联合调强放疗的经验。
Int J Clin Oncol. 2013 Jun;18(3):464-71. doi: 10.1007/s10147-012-0403-y. Epub 2012 Apr 13.
9
Phase II Study of Capecitabine in Substitution of 5-FU in the Chemoradiotherapy Regimen for Patients with Localized Squamous Cell Carcinoma of the Anal Canal.卡培他滨替代5-氟尿嘧啶用于肛管局部鳞状细胞癌患者放化疗方案的II期研究
J Gastrointest Cancer. 2016 Mar;47(1):75-81. doi: 10.1007/s12029-015-9790-4.
10
Treatment outcome of docetaxel, capecitabine and cisplatin regimen for patients with refractory and relapsed nasopharyngeal carcinoma who failed previous platinum-based chemotherapy.多西他赛、卡培他滨和顺铂方案治疗既往铂类化疗失败的复发转移性鼻咽癌患者的疗效。
Expert Opin Pharmacother. 2014 Feb;15(2):163-71. doi: 10.1517/14656566.2014.866652. Epub 2013 Dec 3.
引用本文的文献
1
Cisplatin combined with capecitabine-induced chemotherapy for local nasopharyngeal carcinoma can improve the quality of life and reduce toxic and side effects.顺铂联合卡培他滨诱导化疗治疗局部鼻咽癌可提高生活质量，降低毒副反应。
World J Surg Oncol. 2021 Sep 17;19(1):280. doi: 10.1186/s12957-021-02393-1.
本文引用的文献
1
Epstein-Barr virus-encoded microRNA BART1 induces tumour metastasis by regulating PTEN-dependent pathways in nasopharyngeal carcinoma. Epstein-Barr 病毒编码的 microRNA BART1 通过调节鼻咽癌中 PTEN 依赖性途径诱导肿瘤转移。
Nat Commun. 2015 Jul 2;6:7353. doi: 10.1038/ncomms8353.
2
Capecitabine combined with docetaxel versus vinorelbine followed by capecitabine maintenance medication for first-line treatment of patients with advanced breast cancer: Phase 3 randomized trial.卡培他滨联合多西他赛与长春瑞滨序贯卡培他滨维持治疗用于晚期乳腺癌患者一线治疗：3期随机试验
Cancer. 2015 Oct 1;121(19):3412-21. doi: 10.1002/cncr.29492. Epub 2015 Jun 19.
3
Capecitabine plus oxaliplatin (XELOX) compared with 5-fluorouracil/leucovorin plus oxaliplatin (FOLFOXs) in advanced gastric cancer: meta-analysis of randomized controlled trials.卡培他滨联合奥沙利铂（XELOX方案）与5-氟尿嘧啶/亚叶酸钙联合奥沙利铂（FOLFOX方案）治疗晚期胃癌的比较：随机对照试验的荟萃分析
Eur J Clin Pharmacol. 2015 May;71(5):589-601. doi: 10.1007/s00228-015-1828-9. Epub 2015 Mar 21.
4
Preliminary results of trial NPC-0501 evaluating the therapeutic gain by changing from concurrent-adjuvant to induction-concurrent chemoradiotherapy, changing from fluorouracil to capecitabine, and changing from conventional to accelerated radiotherapy fractionation in patients with locoregionally advanced nasopharyngeal carcinoma.NPC-0501试验的初步结果，该试验评估了局部晚期鼻咽癌患者从同步辅助放化疗改为诱导-同步放化疗、从氟尿嘧啶改为卡培他滨以及从常规放疗分割改为加速放疗分割后的治疗获益情况。
Cancer. 2015 Apr 15;121(8):1328-38. doi: 10.1002/cncr.29208. Epub 2014 Dec 19.
5
Effect of adjuvant capecitabine or fluorouracil, with or without oxaliplatin, on survival outcomes in stage III colon cancer and the effect of oxaliplatin on post-relapse survival: a pooled analysis of individual patient data from four randomised controlled trials.辅助性卡培他滨或氟尿嘧啶（联合或不联合奥沙利铂）对III期结肠癌生存结局的影响以及奥沙利铂对复发后生存的影响：来自四项随机对照试验的个体患者数据汇总分析
Lancet Oncol. 2014 Dec;15(13):1481-1492. doi: 10.1016/S1470-2045(14)70486-3. Epub 2014 Nov 12.
6
Bevacizumab with 5-fluorouracil, leucovorin, and oxaliplatin versus bevacizumab with capecitabine and oxaliplatin for metastatic colorectal carcinoma: results of a large registry-based cohort analysis.贝伐单抗联合5-氟尿嘧啶、亚叶酸钙和奥沙利铂与贝伐单抗联合卡培他滨和奥沙利铂治疗转移性结直肠癌：一项基于大型注册队列分析的结果
BMC Cancer. 2014 May 7;14:323. doi: 10.1186/1471-2407-14-323.
7
Definitive chemoradiotherapy with capecitabine and cisplatin for elder patients with locally advanced squamous cell esophageal cancer.卡培他滨和顺铂同步放化疗治疗局部晚期老年食管鳞癌患者
J Cancer Res Clin Oncol. 2014 May;140(5):867-72. doi: 10.1007/s00432-014-1615-5. Epub 2014 Mar 1.
8
Controversies in the systemic treatment of nasopharyngeal carcinoma.鼻咽癌全身治疗中的争议
Oral Oncol. 2014 Sep;50(9):785-90. doi: 10.1016/j.oraloncology.2014.01.010. Epub 2014 Feb 17.
9
Clinical benefits of concurrent capecitabine and cisplatin versus concurrent cisplatin and 5-flurouracil in locally advanced squamous cell head and neck cancer.卡培他滨与顺铂同步治疗对比顺铂与5-氟尿嘧啶同步治疗对局部晚期头颈部鳞状细胞癌的临床疗效
Drug Discov Ther. 2013 Feb;7(1):36-42. doi: 10.5582/ddt.2013.v7.1.36.
10
Re-irradiation combined with capecitabine in locally recurrent squamous cell carcinoma of the head and neck. A prospective phase II trial.局部复发性头颈部鳞状细胞癌再放疗联合卡培他滨治疗。一项前瞻性 II 期试验。
Strahlenther Onkol. 2012 Mar;188(3):235-42. doi: 10.1007/s00066-011-0040-9. Epub 2012 Feb 10.
Zotero 插件